Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Netherlands,Czech Republic,Russian Federation,New Zealand,France,Germany,Australia,Italy,Hungary,Bulgaria
nct
Update Il y a 5 ans
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
The purpose of the study is to evaluate the clinical efficacy, safety and tolerability of apremilast (30 mg twice daily [BID] and 40 mg BID), compared with placebo, in subjects with active Ulcerative Colitis (UC).
Country
Australia
,
Bulgaria
,
Canada
,
Czech Republic
,
France
,
Germany
,
Hungary
,
Italy
,
Netherlands
,
New Zealand
,
Poland
,
Russian Federation
,
Ukraine
,
United States
,
organs
None
Specialty
None
Opened trial
More information
1